
Colin Kavanagh
+353 1 920 1196
[email protected]
Ten Earlsfort Terrace
Dublin 2
D02 T380
Ireland
Colin is a partner in the Corporate and M&A Group. He is head of the firm’s Life Sciences Group, Media, Entertainment and Sports Group, and Communications Group.
Colin provides corporate, commercial, regulatory and intellectual property advice across a range of industries but in particular the life sciences, food, beverage, agri-business, media, telecoms, sports, entertainment and technology sectors. Colin advises those and other industries on mergers, acquisitions and investments, cross-border tax and intellectual property re-organisations, post-acquisition integrations and corporate treasury activities. Colin advises on the drafting and negotiation of commercial contracts and arrangements a across a range of sectors, with a particular focus on IP based industries. Colin also advises on the regulation of the life sciences and media industries in Ireland.
Relevant Experience
- Advising a US pharmaceutical company on the disposal of a manufacturing plant to a Korean CMO
- Advising Spanish multinational on the acquisition of a Communications infrastructure business in Ireland
- Advising a Canadian business process outsourcing provider on an investment in an Irish business
- Advising the shareholders of an Irish medical device business on a sale to a US multinational
- Advising a US biotech company on the acquisition of an Irish biotech business
- Advising a range of business on supply, sourcing, outsourcing and contract manufacturing arrangements
- Advising pharmaceutical, medtech and biotech businesses on product clinical trials, reimbursement, promotional and transactional regulatory issues
- Advising an Irish telecoms provider on the establishment of a broadcasting platform and the acquisition of a sports broadcaster
- Advising a global media company on the acquisition of an Irish television station
- Advising on the disposal of a number of radio broadcasters to a global media company
Endorsements
“It is always a pleasure to work with the genial Colin Kavanagh.”
The Legal 500: Europe, Middle East and Africa, 2020
Colin Kavanagh is “a very straight shooter”
Chambers Europe: Europe’s Leading Lawyers for Business, 2019
Colin Kavanagh is “practical, collegiate, proactive and solution-focused.”
Chambers Europe: Europe’s Leading Lawyers for Business, 2018
Transaction Star
IP Stars 2022 (Ireland)
Education & Qualifications
- LL M (Commercial Law), 1999, University College, Dublin
- BCL, 1995, University College, Dublin
- Admitted as a solicitor, 1999
- Member of the Irish Pharmaceutical Healthcare Association, affiliate
- Member of Medtech Ireland
- Member of IBEC’s Audio Visual Federation Council
- Member of The Irish Film & Television Academy
- Member of Law Society of Ireland
Related Services
Related Content

Arthur Cox contributes to IBA’s Comparative Legal Guide on Telemedicine

2023 Priority Legislation for Publication in the Life Sciences Sector

Cambrex Corporation acquisition of Q1 Scientific Limited

Biosynth Carbosynth acquisition of Aalto Bio Reagents

PRA Health Sciences proposed acquisition by ICON plc

Arthur Cox named European Corporate Team of the Year

Arthur Cox Leads Mergermarket League Table

Arthur Cox tops Mergermarket M&A Legal Adviser league tables

Arthur Cox Tops Mergermarket M&A Legal Adviser League Tables

Arthur Cox Named M&A Legal Adviser of the Year for Ireland

2023 Priority Legislation for Publication in the Healthcare Sector

Arthur Cox contributes to ICLG Pharmaceutical Advertising 2022

In Vitro Diagnostic Medical Devices Regulation enters into full effect

International Comparative Legal Guide: Digital Health 2022

The Clinical Trial Regulation: Get Ready for Go-Live – Part 3

IPHA publishes new Framework Agreement on the Supply and Pricing of Medicines

The Clinical Trial Regulation: Get Ready for Go-Live – Part 2

The Clinical Trial Regulation: Get Ready for Go-Live – Part 1

IPHA model Clinical Trial Agreement

Arthur Cox contributes to ICLG Pharmaceutical Advertising 2021

HPRA establish Compliance Programme on Advisory Boards

Arthur Cox contributes to Practical Law’s Life Sciences Global Guide 2021

Updates to the Irish Pharmaceutical Healthcare Association (“IPHA”) Codes

Impact of EU/UK Trade and Cooperation Agreement on Life Sciences Sector

New Medical Device Regulations – Are You Ready?
